Zin WarMyintMD

PubMed

• CLO24-080: Association Between Primary Tumor Size and Prognosis in De Novo Metastatic Renal Cell Carcinoma in Patients Who Underwent First Line Immunotherapy-Based The...
  Insija Ilyas Selene, Rani Jayswal, Jennifer C Torres Yee, Heidi L Weiss, Kimberly D Ratliff, Roshmita Bardhan, Amina Dhahri, Zin Myint> ;Journal of the National Comprehensive Cancer Network. 2024 Apr 5
• CLO24-077: Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in the Era of Immunotherapy: An Analysis of the National Cancer Database (NCDB).
  Insija Ilyas Selene, Feitong Lei, Jennifer C Torres Yee, Bin Huang, Amina Dhahri, Jemin Jose, Zin Myint> ;Journal of the National Comprehensive Cancer Network. 2024 Apr 5
• Papillary Renal Cell Carcinoma: Outcomes for Patients Receiving First-line Immune-based Combinations or Tyrosine Kinase Inhibitors from the ARON-1 Study.
  Francesco Massari, Veronica Mollica, Ondrej Fiala, Ugo De Giorgi, Jakub Kucharz, Maria Giuseppa Vitale, Javier Molina-Cerrillo, Gaetano Facchini, Emmanuel Seront, Edoa...> ;European Urology Oncology. 2024 Apr 3
• Case report: Enfortumab vedotin induced refractory DKA and multi organ failure - a rare fatal adverse event.
  Kapoor, A., Ellis, C., Allison, D., Pandey, D., Myint, Z.> ;Frontiers in Oncology. 2024 Jan 1
• TRPS1 expression in primary and metastatic prostatic adenocarcinoma, muscle invasive bladder urothelial carcinoma, and breast carcinoma: Is TRPS1 truly specific and se...
  Bachert, S., Di, J., Zhang, S., Short, H., Piecoro, D., McDonald, R., Myint, Z., Hensley, P., Allison, D.> ;Human Pathology. 2024 Jan 1
• Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study.
  Fernando Sabino Marques Monteiro, Ondřej Fiala, Francesco Massari, Zin W Myint, Jindrich Kopecky, Jakub Kucharz, Thomas Büttner, Enrique Grande, Maria Teresa Bourlon, ...> ;Clinical Genitourinary Cancer. 2024 Apr 1
• The Role of Anticoagulation in Tumor Thrombus Associated with Renal Cell Carcinoma: A Literature Review.
  Chelsey M Williams, Zin W Myint> ;Cancers. 2023 Nov 13
• 2 citations
  Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retros...
  Gilbert, D., Ondřej Fiala, Sebastiano Buti, Hideki Takeshita, Yohei Okada, Francesco Massari, Georgia Anguera Palacios, Michele Dionese, Sarah Scagliarini, Thomas Bütt...> ;Cancer Immunology, Immunotherapy. 2023 Nov 1
• 1 citations
  Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study.
  Gilbert, D., Matteo Santoni, Zin W Myint, Thomas Büttner, Hideki Takeshita, Yohei Okada, Elaine T Lam, Danielle Gilbert, Zsófia Küronya, Deniz Tural, Renate Pichler, E...> ;Cancer Immunology, Immunotherapy. 2023 Sep 1
• Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
  Camillo Porta, Aristotelis Bamias, Roubini Zakopoulou, Zin W Myint, Nicolò Cavasin, Roberto Iacovelli, Martin Pichler, Jindrich Kopecky, Jakub Kucharz, Mimma Rizzo, Lu...> ;Minerva Urology and Nephrology. 2023 Aug 1
• 4 citations
  Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Crit...
  Matteo Santoni, Sebastiano Buti, Zin W Myint, Marco Maruzzo, Roberto Iacovelli, Martin Pichler, Jindrich Kopecky, Jakub Kucharz, Mimma Rizzo, Luca Galli, Thomas Büttne...> ;European Urology Oncology. 2024 Feb 1
• 5 citations
  Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.
  Matteo Santoni, Francesco Massari, Zin W Myint, Roberto Iacovelli, Martin Pichler, Umberto Basso, Jindrich Kopecky, Jakub Kucharz, Sebastiano Buti, Mimma Rizzo, Luca G...> ;Targeted Oncology. 2023 Jul 1
• 2 citations
  Association of CD47 Expression with Clinicopathologic Characteristics and Survival Outcomes in Muscle Invasive Bladder Cancer.
  Zin W Myint, Zena Chahine, Rani Jayswal, Emily Bachert, Robert J McDonald, Stephen E Strup, Andrew C James, Patrick J Hensley, Derek B Allison> ;Journal of Personalized Medicine. 2023 May 24
• 1 citations
  A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer.
  Zin W Myint, William H St Clair, Stephen E Strup, Donglin Yan, Ning Li, Derek B Allison, Laurie E McLouth, Carleton S Ellis, Peng Wang, Andrew C James, Patrick J Hensl...> ;Cancers. 2023 Apr 27
• 4 citations
  Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations...
  Matteo Santoni, Francesco Massari, Zin W Myint, Roberto Iacovelli, Martin Pichler, Umberto Basso, Jindrich Kopecky, Jakub Kucharz, Sebastiano Buti, Alessia Salfi, Thom...> ;Clinical Genitourinary Cancer. 2023 Oct 1
• Primary mediastinal seminoma presenting with paraneoplastic anti-Hu encephalitis: a case report and literature review.
  Chelsey M Williams, Derek B Allison, Adam B Coleman, Roshmita Bardhan, Jordan D Miller, Zin W Myint> ;Frontiers in Oncology. 2023 Jan 1
• Correlation Between Trough Level of Abiraterone and Prostate-Specific Antigen (PSA) Response in Metastatic Hormone-Sensitive Prostate Cancer.
  Zin W Myint, Jill M Kolesar, Joseph Robert McCorkle, Jianrong Wu, Carleton S Ellis, Danielle E Otto, Peng Wang> ;Medical Science Monitor. 2022 Oct 14
• 4 citations
  Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study.
  Alessandro Rizzo, Veronica Mollica, Andrea Marchetti, Giacomo Nuvola, Matteo Rosellini, Elisa Tassinari, Javier Molina-Cerrillo, Zin W Myint, Tomas Buchler, Fernando S...> ;Cancers. 2022 Aug 26
• 4 citations
  Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies.
  Matteo Santoni, Javier Molina-Cerrillo, Zin W Myint, Francesco Massari, Tomas Buchler, Sebastiano Buti, Marc R Matrana, Ugo De Giorgi, Mimma Rizzo, Ignacio Ortego Zaba...> ;Targeted Oncology. 2022 Sep 1
• 8 citations
  Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival.
  Matteo Santoni, Fernando Sabino M Monteiro, Francesco Massari, Halima Abahssain, Gaetano Aurilio, Javier Molina-Cerrillo, Zin W Myint, Ignacio Ortego Zabalza, Nicola B...> ;Critical Reviews in Oncology/hematology. 2022 Aug 1
• A single arm phase II study of bone-targeted Sn-117 m-DTPA in symptomatic castration-resistant prostate cancer with skeletal metastases.
  Zin W Myint, Riham El Khouli, Bryan Lemieux, Donglin Yan, William H St Clair, Xiaoqi Liu, Charles A Kunos> ;BMC Cancer. 2022 Apr 15
• 2 citations
  Case Report: Safety and Efficacy of Enfortumab Vedotin in a Patient With Metastatic Urothelial Carcinoma Undergoing Peritoneal Dialysis.
  Kaylyn R Collette, Zin W Myint, Saurabh V Parasramka, Carleton S Ellis> ;Frontiers in Oncology. 2022 Jan 1
• 3 citations
  Hematological adverse events in the management of glioblastoma.
  Catherine R Garcia, Zin W. Myint, Rani Jayswal, Chi Wang, Rachael M. Morgan, Allison R Butts, Heidi L. Weiss, John L. Villano> ;Journal of Neuro-Oncology. 2021 Nov 24
• 29 citations
  Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies.
  Aasems Jacob, Rishi Raj, Derek B. Allison, Zin W. Myint> ;Cancers. 2021 Oct 28
• 4 citations
  Pituitary apoplexy induced by gonadotropin-releasing hormone (GnRH) agonist administration for treatment of prostate cancer: a systematic review
  Rishi Raj, Ghada Elshimy, Aasems Jacob, P. V. Akhila Arya, Dileep Unnikrishnan, Riccardo Correa, Zin W. Myint> ;Journal of Cancer Research and Clinical Oncology. 2021 Jun 22
• Join now to see all

Lectures

• Immune-related adverse events for different age groups using the FDA Adverse Event Reporting System. 
  2019 ASCO Annual Meeting - 6/1/2019